Acura Pharmaceuticals Inc (ACUR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0198 unch (unch) 03/26/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0198 unch (unch) 09:36 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -879 | -1,208 | -3,774 | -3,842 | -5,682 |
| Depreciation Amortization | 90 | 125 | 339 | 367 | 393 |
| Accounts receivable | 119 | -119 | -78 | -66 | 102 |
| Accounts payable and accrued liabilities | 161 | -206 | -368 | 602 | -74 |
| Other Working Capital | 477 | -117 | 121 | -183 | 268 |
| Other Operating Activity | -710 | 806 | 3,142 | -786 | 483 |
| Operating Cash Flow | $-742 | $-719 | $-618 | $-3,908 | $-4,510 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 103 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 206 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $309 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 416 | 269 | 1,375 | 4,350 | -2,760 |
| Debt Repayment | -17 | N/A | N/A | -2,573 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 4,000 |
| Other Financing Activity | -5 | 1 | 14 | 2 | 0 |
| Financing Cash Flow | $394 | $270 | $1,389 | $1,779 | $1,240 |
| Beginning Cash Position | 413 | 862 | 91 | 2,220 | 5,181 |
| End Cash Position | 65 | 413 | 862 | 91 | 2,220 |
| Net Cash Flow | $-348 | $-449 | $771 | $-2,129 | $-2,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -742 | -719 | -618 | -3,908 | -4,510 |
| Free Cash Flow | -742 | -719 | -618 | -3,908 | -4,510 |